Skip to main content
. 2020 Dec 22;2020:8864813. doi: 10.1155/2020/8864813

Figure 3.

Figure 3

Expression of PPAR β/δ and ligand activation of target gene (PDK1) in cholesteatoma keratinocytes. (a, c) Expression of PPAR β/δ was quantified by immunoblot after treating with 100 nM GW0742 (a) or 5 μM GSK0660 (c) for 24 h. (e, g) The effect of PPAR β/δ agonist (e) or antagonist (g) on expression of the PPAR β/δ-dependent target gene PDK1 was determined by immunoblot following ligand activation of PPAR β/δ with 100 nM GW0742 or 5 μM GSK0660 for 24 h. (b, d, f, and h) Data are expressed as the mean ± SD of the mean for experiments run in triplicate. ∗p < 0.05 (vs. control group).